Insider · CIK 0001859701
Andrew Spaventa
Files at OMIC (Singular Genomics Systems, Inc.). First filing Nov 20, 2023, latest Dec 17, 2024.
In brief
Andrew Spaventa files SEC Form 4 as CEO and director at OMIC (Singular Genomics Systems, Inc.). Since Nov 20, 2023, Andrew Spaventa has reported 1 open-market buy worth $50k and 2 open-market sells worth $19k, the latest filed on Dec 17, 2024.
A track record needs three past buys with six months of prices behind them; Andrew Spaventa has 0, so none is measured yet.
The newest scored trade: sold $3,629 of OMIC on Dec 16, 2024, filed Dec 17, 2024, scored 15 (weak).
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 15Weak | OMICsell Singular Genomics Systems, Inc. | $3,629 180 shares | -22% | - | |
| 20Weak | OMICsell Singular Genomics Systems, Inc. | $16k 695 shares | -31% | - | |
| 40Moderate | Singular Genomics Systems, Inc. | $50k 118,468 shares | +3% | - |
Transactions
Every row this insider has filed, 16 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 15, 2024 | OMIC Singular Genomics Systems, Inc. | MOption exercise Common Stock | +486 | - | - | 811 | Dec 17, 2024 |
| Dec 16, 2024 | OMIC Singular Genomics Systems, Inc. | SOpen-market sale Common Stock | -180 | $20.16 | $3,629 | 631 | Dec 17, 2024 |
| Dec 16, 2024 | OMIC Singular Genomics Systems, Inc. | GGift Common Stock | -306 | $0.00 | $0 | 325 | Dec 17, 2024 |
| Dec 16, 2024 | OMIC Singular Genomics Systems, Inc. | GGift Common Stockindirect: By The Andrew K. Spaventa Living Trust dated April 9, 2014 | +306 | $0.00 | $0 | 141,793 | Dec 17, 2024 |
| Dec 15, 2024 | OMIC Singular Genomics Systems, Inc. | MOption exercise Restricted Stock Unitsderivative | -486 | $0.00 | $0 | 4,374 | Dec 17, 2024 |
| Nov 12, 2024 | OMIC Singular Genomics Systems, Inc. | MOption exercise Common Stock | +1,907 | - | - | 2,232 | Nov 13, 2024 |
| Nov 12, 2024 | OMIC Singular Genomics Systems, Inc. | SOpen-market sale Common Stock | -695 | $22.55 | $16k | 1,537 | Nov 13, 2024 |
| Nov 12, 2024 | OMIC Singular Genomics Systems, Inc. | GGift Common Stock | -1,212 | $0.00 | $0 | 325 | Nov 13, 2024 |
| Nov 12, 2024 | OMIC Singular Genomics Systems, Inc. | GGift Common Stockindirect: By The Andrew K. Spaventa Living Trust dated April 9, 2014 | +1,212 | $0.00 | $0 | 141,487 | Nov 13, 2024 |
| Nov 12, 2024 | OMIC Singular Genomics Systems, Inc. | MOption exercise Restricted Stock Unitsderivative | -1,907 | $0.00 | $0 | 24,780 | Nov 13, 2024 |
| Dec 15, 2023 | OMIC Singular Genomics Systems, Inc. | MOption exercise Common Stock | +14,583 | - | - | 24,349 | Dec 18, 2023 |
| Dec 15, 2023 | OMIC Singular Genomics Systems, Inc. | GGift Common Stock | -14,583 | $0.00 | $0 | 9,766 | Dec 18, 2023 |
| Dec 15, 2023 | OMIC Singular Genomics Systems, Inc. | GGift Common Stockindirect: By The Andrew K. Spaventa Living Trust dated April 9, 2014 | +14,583 | $0.00 | $0 | 4,075,789 | Dec 18, 2023 |
| Dec 15, 2023 | OMIC Singular Genomics Systems, Inc. | MOption exercise Restricted Stock Unitsderivative | -14,583 | - | - | 189,583 | Dec 18, 2023 |
| Nov 16, 2023 | OMIC Singular Genomics Systems, Inc. | POpen-market purchase Common Stockindirect: By The Andrew K. Spaventa Living Trust dated April 9, 2014 | +43,468 | $0.41 | $18k | 3,986,206 | Nov 20, 2023 |
| Nov 17, 2023 | OMIC Singular Genomics Systems, Inc. | POpen-market purchase Common Stockindirect: By The Andrew K. Spaventa Living Trust dated April 9, 2014 | +75,000 | $0.42 | $32k | 4,061,206 | Nov 20, 2023 |
Questions about Andrew Spaventa
Answered from the filings on this page, as of the latest one.
Is Andrew Spaventa buying or selling?
Not in the last 12 months. Andrew Spaventa's latest open-market trade on SEC Form 4 was sold $3,629 of OMIC on Dec 16, 2024.
How did Andrew Spaventa's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Andrew Spaventa has 0.
Where does Andrew Spaventa file Form 4?
Andrew Spaventa has filed Form 4 at OMIC (Singular Genomics Systems, Inc.) as Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.